drugset / Trial / NCT00296777

Treatment of Depression Following Multiple Brain Tests

NCT00296777

Phase 4 Completed 28 enrolled New York State Psychiatric Institute
Non-randomizedCrossoverOpen-labelTreatment

Summary

The main purpose of this study is to correlate brain testing with treatment outcome.

Timeline

Start
2004-12
Primary completion
2007-05
Completion
2007-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupropion Small molecule 450 mg
Subject Escitalopram Small molecule 40 mg
Subject Imipramine Small molecule 300 mg